Publicaciones en las que colabora con Alvaro Urbano Ispizua (20)

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2015

  1. The genotype of the donor for the (GT)n polymorphism in the promoter/enhancer of FOXP3 Is associated with the development of severe acute GVHD but does not affect the GVL effect after myeloablative HLA-Identical allogeneic stem cell transplantation

    PLoS ONE, Vol. 10, Núm. 10

2010

  1. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays

    Journal of Clinical Virology, Vol. 48, Núm. 2, pp. 142-146

2007

  1. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors

    Blood, Vol. 110, Núm. 1, pp. 461-467

2004

  1. Elderly age and prior autologous transplantation have a deleterious effect on survival following allogenic peripheral blood stem cell transplantation with reduced-intensity conditioning: Results from the Spanish multicenter prospective trial

    Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 477-482

2003

  1. Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

    Experimental Hematology

2002

  1. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: Incidence and risk factors in 395 patients

    British Journal of Haematology, Vol. 116, Núm. 2, pp. 475-482

  2. Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34 + selected blood cells from HLA-identical siblings

    Blood, Vol. 100, Núm. 2, pp. 724-727

2001

  1. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: Results of a prospective multicentre study

    British Journal of Haematology, Vol. 115, Núm. 3, pp. 653-659

  2. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies

    British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550

  3. Severe infections after allogeneic peripheral blood stem cell transplantation: A matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation

    Haematologica, Vol. 86, Núm. 10, pp. 1075-1086

  4. The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings

    Blood, Vol. 97, Núm. 2, pp. 383-387

2000

  1. Reduced-intensity conditioning for allogeneic transplantation in hematologic malignancies. results of a prospective multicenter study

    Blood, Vol. 96, Núm. 11 PART II

  2. The number of donor CD34+ and CD3+ cells is the most important factor for disease free survival after allogeneic transplantation of CD34+ selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings

    Hematology and Cell Therapy

  3. The number of donor cd3+ cells is the most important factor for graft failure after allogeneic transplantation of cd34+ selected cells from peripheral blood (allo-pbt/cd34+) from hla-identical siblings

    Blood, Vol. 96, Núm. 11 PART II

1998

  1. Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique

    Bone Marrow Transplantation, Vol. 22, Núm. 6, pp. 519-525

  2. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study

    Bone Marrow Transplantation, Vol. 22, Núm. 12, pp. 1129-1135

1997

  1. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation

    Haematologica, Vol. 82, Núm. 6, pp. 683-689

  2. Trasplante alogénico de células CD34+ de sangre periférica de donantes HLA-idénticos: Experiencia española de 40 casos

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 44-45

  3. Trasplante alogénico de progenitores hemopoyéticos de sangre periférica no manipulados: Experiencia española de 79 casos

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 42-43